Literature DB >> 24695467

Granulocyte, monocyte and blast immunophenotype abnormalities in acute myeloid leukemia with myelodysplasia-related changes.

Sonali P Ayar1, Sreelakshmi Ravula, Jacek M Polski.   

Abstract

Little literature exists regarding granulocyte and monocyte immunophenotype abnormalities in Acute Myeloid Leukemia (AML). We hypothesized that granulocyte and monocyte immunophenotype abnormalities are common in AML, and especially in AML with myelodysplasia-related changes (AMLMRC). Bone marrow or peripheral blood specimens from 48 cases of AML and 22 cases of control specimens were analyzed by flow cytometric immunophenotyping. Granulocyte, monocyte, and blast immunophenotype abnormalities were compared between cases of AML versus controls and AMLMRC versus AML without myelodysplasia. The results revealed that granulocyte, monocyte, and blast abnormalities were more common in AMLMRC than in AML without myelodysplasia or control cases. The difference reached statistical significance for abnormalities of granulocytes and abnormalities in all cells of interest. From the numerous individual abnormalities, only CD25 expression in blasts was significantly more prevalent in AMLMRC in this study. We conclude that detection of granulocyte, monocyte, and blast immunophenotype abnormalities can contribute to the diagnosis of AMLMRC.

Entities:  

Keywords:  Acute Myeloid Leukemia; Blast; Flow cytometry; Granulocyte; Monocyte

Mesh:

Substances:

Year:  2014        PMID: 24695467

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  1 in total

1.  Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy.

Authors:  Quanyin Hu; Wujin Sun; Jinqiang Wang; Huitong Ruan; Xudong Zhang; Yanqi Ye; Song Shen; Chao Wang; Weiyue Lu; Ke Cheng; Gianpietro Dotti; Joshua F Zeidner; Jun Wang; Zhen Gu
Journal:  Nat Biomed Eng       Date:  2018-10-29       Impact factor: 25.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.